• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

访谈:从树木、树枝/树枝状大分子到纳米医学的建筑之旅。访谈者:Hannah Stanwix。

Interview: An architectural journey: from trees, dendrons/dendrimers to nanomedicine. Interview by Hannah Stanwix.

机构信息

National Dendrimer & Nanotechnology Center/NanoSynthons LLC, 1200 N Fancher Avenue, MI, USA.

出版信息

Nanomedicine (Lond). 2012 Jul;7(7):953-6. doi: 10.2217/nnm.12.81.

DOI:10.2217/nnm.12.81
PMID:22846090
Abstract

Donald Tomalia received his Bachelor of Arts degree in Chemistry from the University of Michigan (MI, USA). He received his PhD in physical-organic Chemistry from Michigan State University (MI, USA) in 1968 while working at The Dow Chemical Company (MI, USA). In 1990 he moved to Michigan Molecular Institute (MI, USA) as Professor and Director of Nanoscale Chemistry and Architecture. He has subsequently founded three dendrimer based-nanotechnology companies, Dendritech, Inc. (MI, USA), Dendritic Nanotechnologies, Inc. (MI, USA) and NanoSynthons LLC (MI, USA). Donald Tomalia is currently Director of the National Dendrimer & Nanotechnology Center (MI, USA), CEO/founder of NanoSynthons LLC (MI, USA), distinguished visiting Professor, Columbia University (NY, USA) and affiliate Professor, Department of Physics, Virginia Commonwealth University (VA, USA). He is best known for his discovery of dendrimers and has received several awards for his accomplishments and contributions to science, including the 2012 Wallace H Carothers Award. He has authored over 250 publications, as well as over 128 patents.

摘要

唐纳德·汤姆利(Donald Tomalia)毕业于美国密歇根大学(University of Michigan,简称密歇根大学或 UMich),获化学专业文学学士学位。他于 1968 年在美国密歇根州立大学(Michigan State University,简称密歇根州立大学或 MSU)获得物理有机化学博士学位,期间在美国陶氏化学公司(The Dow Chemical Company,简称陶氏化学或 Dow)工作。1990 年,他前往密歇根分子研究所(Michigan Molecular Institute,简称密歇根分子研究所或 MMI),担任纳米化学和架构教授兼主任。此后,他创立了三家基于树状聚合物的纳米技术公司:Dendritech, Inc.(美国密歇根州)、Dendritic Nanotechnologies, Inc.(美国密歇根州)和 NanoSynthons LLC(美国密歇根州)。唐纳德·汤姆利(Donald Tomalia)现任美国国家树状聚合物与纳米技术中心主任、NanoSynthons LLC(美国密歇根州)首席执行官/创始人、哥伦比亚大学(Columbia University,简称哥伦比亚大学或 CU)名誉客座教授、弗吉尼亚联邦大学(Virginia Commonwealth University,简称 VCU)物理系兼职教授。他因发现树状聚合物而闻名于世,并因其在科学领域的成就和贡献获得了多项奖项,包括 2012 年华莱士·H·卡罗瑟斯奖(Wallace H. Carothers Award)。他撰写了 250 多篇出版物和 128 多项专利。

相似文献

1
Interview: An architectural journey: from trees, dendrons/dendrimers to nanomedicine. Interview by Hannah Stanwix.访谈:从树木、树枝/树枝状大分子到纳米医学的建筑之旅。访谈者:Hannah Stanwix。
Nanomedicine (Lond). 2012 Jul;7(7):953-6. doi: 10.2217/nnm.12.81.
2
Interview: An interview with Chad Mirkin: nanomedicine expert. Interviewed by Hannah Stanwix.访谈:专访 Chad Mirkin:纳米医学专家。访谈者:Hannah Stanwix。
Nanomedicine (Lond). 2012 May;7(5):635-8. doi: 10.2217/nnm.12.44.
3
Leading the way in biomedical engineering: an interview with Robert Langer. Interview by Hannah Stanwix, Commissioning Editor.引领生物医学工程领域:罗伯特·兰格访谈。访谈者:汉娜·斯坦威克斯,委托编辑。
Nanomedicine (Lond). 2012 Oct;7(10):1483-4. doi: 10.2217/nnm.12.132.
4
Interview: Nanomedicine: past, present and future.访谈:纳米医学:过去、现在与未来。
Nanomedicine (Lond). 2013 Apr;8(4):525-9. doi: 10.2217/nnm.13.37.
5
Nanostructures for sensors and analytical systems.用于传感器和分析系统的纳米结构。
Nanomedicine (Lond). 2012 Mar;7(3):317-9. doi: 10.2217/nnm.12.15.
6
Interview with Vladimir P Torchilin: liposomal carriers for drug delivery.
Ther Deliv. 2013 May;4(5):537-8. doi: 10.4155/tde.13.25.
7
Interview with Professor Jindřich Kopeček.对金德里希·科佩切克教授的采访。
Nanomedicine (Lond). 2014 Apr;9(5):577-9. doi: 10.2217/nnm.14.20.
8
Interview with James Bradner. Interviewed by Hannah Coaker.詹姆斯·布拉德纳访谈。采访人:汉娜·科克。
Future Med Chem. 2013 Aug;5(12):1373-6. doi: 10.4155/fmc.13.124.
9
Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by Emily Culme-Seymour.访谈:基于细胞的治疗和再生医学的商业翻译:经验学习。访谈者:艾米丽·卡尔梅-西摩。
Regen Med. 2011 Jul;6(4):431-5. doi: 10.2217/rme.11.40.
10
Patrick Couvreur: inspiring pharmaceutical innovation.帕特里克·库夫勒:激发制药创新。
Nanomedicine (Lond). 2014 May;9(6):759-61. doi: 10.2217/nnm.14.24.

引用本文的文献

1
Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders.用于遗传性视网膜疾病的核酸运输非病毒递送系统。
Pharmaceuticals (Basel). 2025 Jan 13;18(1):87. doi: 10.3390/ph18010087.
2
Theranostic Diagnostics.治疗诊断学。
Results Probl Cell Differ. 2024;73:551-578. doi: 10.1007/978-3-031-62036-2_22.
3
Dendrimer-Mediated Delivery of DNA and RNA Vaccines.树枝状聚合物介导的DNA和RNA疫苗递送
Pharmaceutics. 2023 Mar 30;15(4):1106. doi: 10.3390/pharmaceutics15041106.
4
Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage.用于骨关节炎治疗的关节内药物输送系统:从持续释放到增强向软骨渗透的转变。
Drug Deliv. 2022 Dec;29(1):767-791. doi: 10.1080/10717544.2022.2048130.
5
A Review on Drug Delivery System for Tumor Therapy.肿瘤治疗药物递送系统综述
Front Pharmacol. 2021 Oct 4;12:735446. doi: 10.3389/fphar.2021.735446. eCollection 2021.
6
Dendrimers for Drug Delivery.树枝状聚合物用于药物递送。
Molecules. 2018 Apr 18;23(4):938. doi: 10.3390/molecules23040938.